1. Home
  2. ARQT vs AVAH Comparison

ARQT vs AVAH Comparison

Compare ARQT & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$29.68

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Logo Aveanna Healthcare Holdings Inc.

AVAH

Aveanna Healthcare Holdings Inc.

HOLD

Current Price

$8.84

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARQT
AVAH
Founded
2016
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
1.9B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
ARQT
AVAH
Price
$29.68
$8.84
Analyst Decision
Strong Buy
Buy
Analyst Count
7
9
Target Price
$24.83
$10.19
AVG Volume (30 Days)
1.8M
1.3M
Earning Date
02-24-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.37
Revenue
$317,929,000.00
$2,290,591,000.00
Revenue This Year
$85.51
$20.08
Revenue Next Year
$30.74
$7.12
P/E Ratio
N/A
$24.14
Revenue Growth
129.21
15.48
52 Week Low
$11.13
$3.67
52 Week High
$31.77
$10.32

Technical Indicators

Market Signals
Indicator
ARQT
AVAH
Relative Strength Index (RSI) 55.12 52.55
Support Level $27.71 $7.68
Resistance Level $30.26 $9.27
Average True Range (ATR) 1.17 0.32
MACD -0.09 -0.02
Stochastic Oscillator 66.45 71.38

Price Performance

Historical Comparison
ARQT
AVAH

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Share on Social Networks: